Clinical trial
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional…
NCT00056524 · Avanir Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00056524 |
|---|---|
| Title | Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) |
| Official title | An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect. |
| Lead sponsor | Avanir Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease, Stroke, Parkinson's Disease, Traumatic Brain Injury |
| Intervention type | Drug |
| Interventions | AVP-923 |
| Enrollment | 600 |
| Start date | Feb 1, 2003 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Mar 18, 2003 |
| Last update posted | Jul 14, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: